Expertise in
28
conditions

Dr. Mark E. Molitch

Endocrinology
680 N Lake Shore Dr, Suite 1000, 
Chicago, IL 
Expertise in
28
conditions
680 N Lake Shore Dr, Suite 1000, 
Chicago, IL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Mark Molitch is an Endocrinologist in Chicago, Illinois. Dr. Molitch is highly rated in 28 conditions, according to our data. His top areas of expertise are Acromegaloid Facial Appearance Syndrome, Hypertrichosis-Acromegaloid Facial Appearance Syndrome, Acromegaly, Hormone Replacement Therapy (HRT), and Parathyroidectomy.

His clinical research consists of co-authoring 163 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Endocrinology
Licenses
Internal Medicine in IL
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

680 N Lake Shore Dr, Suite 1000, Chicago, IL 60611

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

An Open-label, Multi-center, Roll-over Study to Assess Long Term Safety in Patients With Endogenous Cushing's Syndrome Who Have Completed a Prior Novartis-sponsored Osilodrostat (LCI699) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Osilodrostat
An Open-label, Multi-center, Roll-over Study to Assess Long Term Safety in Patients With Endogenous Cushing's Syndrome Who Have Completed a Prior Novartis-sponsored Osilodrostat (LCI699) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Osilodrostat
Enrollment Status: Completed
Publish Date: December 18, 2024
Intervention Type: Drug
Study Drug: Osilodrostat
Study Phase: Phase 2
An Open-label Extension Study of Levoketoconazole (2S,4R-ketoconazole) in the Treatment of Endogenous Cushing's Syndrome
An Open-label Extension Study of Levoketoconazole (2S,4R-ketoconazole) in the Treatment of Endogenous Cushing's Syndrome
Enrollment Status: Completed
Publish Date: May 10, 2023
Intervention Type: Drug
Study Drug: Levoketoconazole
Study Phase: Phase 3
A Double-blind, Placebo-Controlled, Randomized Withdrawal Following Open Label Therapy Study to Assess the Safety and Efficacy of Levoketoconazole (2S, 4R-ketoconazole) in the Treatment of Endogenous Cushing's Syndrome
A Double-blind, Placebo-Controlled, Randomized Withdrawal Following Open Label Therapy Study to Assess the Safety and Efficacy of Levoketoconazole (2S, 4R-ketoconazole) in the Treatment of Endogenous Cushing's Syndrome
Enrollment Status: Completed
Publish Date: November 08, 2022
Intervention Type: Drug
Study Phase: Phase 3
PERL (Preventing Early Renal Loss in Diabetes) Continuous Glucose Monitoring (CGM) Study
PERL (Preventing Early Renal Loss in Diabetes) Continuous Glucose Monitoring (CGM) Study
Enrollment Status: Completed
Publish Date: March 29, 2022
Intervention Type: Other, Drug
Phase III, Multi-center, Double-blind, Randomized Withdrawal Study of LCI699 Following a 24 Week, Single-arm, Open-label Dose Titration and Treatment Period to Evaluate the Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease
Phase III, Multi-center, Double-blind, Randomized Withdrawal Study of LCI699 Following a 24 Week, Single-arm, Open-label Dose Titration and Treatment Period to Evaluate the Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease
Enrollment Status: Completed
Publish Date: January 06, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

163 Total Publications

Associations of Kidney Tubular Biomarkers With Incident Macroalbuminuria and Sustained Low eGFR in DCCT/EDIC.
Associations of Kidney Tubular Biomarkers With Incident Macroalbuminuria and Sustained Low eGFR in DCCT/EDIC.
Journal: Diabetes care
Published: November 15, 2023
Similar Doctors
Expertise in
9
conditions
Dr. Samuel Refetoff
Endocrinology
Expertise in
9
conditions
Dr. Samuel Refetoff
Endocrinology

The University Of Chicago Medical Center

5841 S Maryland Ave, 
Chicago, IL 
 (7.3 mi)
773-702-1000
Languages Spoken:
English, Bulgarian, French, Italian, Spanish
See accepted insurances
Accepting New Patients

Samuel Refetoff is an Endocrinologist in Chicago, Illinois. Dr. Refetoff is highly rated in 9 conditions, according to our data. His top areas of expertise are Allan-Herndon-Dudley Syndrome, Hypothyroidism, Congenital Hypothyroidism, and Generalized Resistance to Thyroid Hormone. Dr. Refetoff is currently accepting new patients.

Expertise in
11
conditions
Dr. Grazia M. Aleppo
Endocrinology
Expertise in
11
conditions
Dr. Grazia M. Aleppo
Endocrinology

Northwestern Medical Faculty Foundation

675 N Saint Clair St, 
Chicago, IL 
 (0.3 mi)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Grazia Aleppo is an Endocrinologist in Chicago, Illinois. Dr. Aleppo is highly rated in 11 conditions, according to our data. Her top areas of expertise are Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Low Blood Sugar, and Maturity Onset Diabetes of the Young. Dr. Aleppo is currently accepting new patients.

Expertise in
50
conditions
Dr. Pauline M. Camacho
Endocrinology
Expertise in
50
conditions
Dr. Pauline M. Camacho
Endocrinology

Loyola University Medical Center

1 S260 Summit Ave, 
Oakbrook Terrace, IL 
 (18.6 mi)
630-953-6600
Languages Spoken:
English, Filipino
See accepted insurances
Accepting New Patients
Offers Telehealth

Pauline Camacho is an Endocrinologist in Oakbrook Terrace, Illinois. Dr. Camacho is highly rated in 50 conditions, according to our data. Her top areas of expertise are Osteoporosis, Postmenopausal Osteoporosis, Juvenile Primary Osteoporosis, Hyperparathyroidism, and Parathyroidectomy. Dr. Camacho is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Molitch's expertise for a condition
ConditionClose
View All 14 Distinguished Conditions
View All 11 Advanced Conditions
View All 37 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile